Your browser doesn't support javascript.
loading
Dose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma: not yet the standard of care.
Casan, Joshua Ml; Barraclough, Alison; Shortt, Jake; Hawkes, Eliza A.
Affiliation
  • Casan JM; Haematology Department, Monash Health, Melbourne, VIC, Australia; School of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia.
  • Barraclough A; The Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia.
  • Shortt J; School of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia; School of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia.
  • Hawkes EA; The Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia. Electronic address: Eliza.Hawkes@onjcri.org.au.
Lancet Haematol ; 6(3): e119, 2019 03.
Article in En | MEDLINE | ID: mdl-30824036
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Large B-Cell, Diffuse / Standard of Care Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Lancet Haematol Year: 2019 Document type: Article Affiliation country: Australia Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Large B-Cell, Diffuse / Standard of Care Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Lancet Haematol Year: 2019 Document type: Article Affiliation country: Australia Country of publication: United kingdom